Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma

NCT05027594 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped The decision is not based on emerging safety or efficacy concerns but on strategic reasons related to the changing and competitive treatment options in Multiple Myeloma

Conditions

Interventions

Sponsor

Nerviano Medical Sciences